-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURISIN US4781601046-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046EURSymbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartEURSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenEURSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgEURSymbol JNJ
-
USDJohnson & JohnsonBörse SGO
-
USDJohnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
ISIN US4781601046
Symbol JNJ
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Marktkapitalisierung
99.567.000.000
Mitarbeiter
141.700
Zahlte zuletzt am 25.05.2021 eine Dividende von 1,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 14,66 % p. a.
beim aktuellen Kurs von 137,58 EUR +0,02%
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
1.987 News & Informationen zur Johnson & Johnson Aktie
Delaware Latest To Lift Hurdle To Nurse Practitioners During Pandemic
Delaware is the latest in a growing number of states giving direct access to nurse practitioners thanks to legislation eliminating hurdles for patients who need primary care, particularly during the Covid-19 pandemic.
Biotech vs. Pharmaceuticals: What's the Difference?
Biotech and pharma are important industry sectors that differ fundamentally in how they derive medical or healthcare treatments.
Torray LLC Buys VMware Inc, Fiserv Inc, KLA Corp, Sells Oracle Corp, The Kraft Heinz Co, Motorola Solutions Inc
GuruFocus Article or News written by insider and the topic is about:
How COVID-19 vaccine supply chains emerged in the midst of a pandemic
Many months after COVID-19 vaccines were first authorized for public use, still limited supplies could only partially reduce the devastating loss of life and economic costs caused by the pandemic. Could additional vaccine doses have been manufactured more quickly some other way?
Avicanna Announces Partial Revocation of Cease Trade Order and Proposed Financing
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) — Avicanna Inc. (the “Company” or “Avicanna”) (TSX:AVCN) announces that the Ontario Securities Commission …
ASX Today: Record close in the US signals gains ahead
Hundreds of migrants vaccinated against coronavirus in U.S.-Mexico border city By Reuters
Hundreds of migrants vaccinated against coronavirus in U.S.-Mexico border city
'Stay tuned': Delta CEO says he won't require customers to be vaccinated without full FDA approval
Businesses and cities have been enacting vaccination requirements for indoor patrons but airlines haven't been quick to follow.
Accel Wealth Management Buys First Trust International IPO ETF, Barclays Bank PLC ZC SP ETN REDEEM 12/10/2022 USD , Natixis Loomis Sayles Short Duration Income ETF, Sells iShares Core U.S. Aggregate B
GuruFocus Article or News written by insider and the topic is about:
Focused Investors LLC Buys CVS Health Corp, L3Harris Technologies Inc
GuruFocus Article or News written by insider and the topic is about:
Global Top Selling Biologics Markets 2021-2030: Humira, Keytruda, Opdivo, Avastin, Rituxan, Stelara, Herceptin, Enbrel
/PRNewswire/ — The “Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis,…
Why Pfizer Shot 4% Higher Today
New York City introduces a sweeping vaccination mandate, as authorities struggle to keep the coronavirus at bay.
What the ETF? Investors look for ASX ETFs with access to cybersecurity and COVID-19 vaccines
Topping the ASX ETF market in July was one of the few cybersecurity-focused ETFs in BetaShares' Global Cybersecurity ETF (ASX:HACK).
U.S. administers 347.4 million doses of COVID-19 vaccines
U.S. administers 347.4 million doses of COVID-19 vaccines – CDC
Decision to mix vaccines could cause travel difficulties for millions of Canadians
As of Monday, 67.6 per cent of eligible Canadians are fully vaccinated, including about 3.6-million people who received a combination of vaccines
Sanofi bets big on mRNA vaccines, to buy Translate Bio for $3.2 bn
The firm said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion
Diversified Portfolios, Inc. Buys Altair Engineering Inc, Vanguard ESG U.S. Stock ETF, Vanguard ESG International Stock ETF, Sells Vanguard Short-Term Bond ETF, Vanguard Intermediate-Term Bond ETF, Sh
GuruFocus Article or News written by insider and the topic is about:
News alert: FMOL system mandates vaccines for all employees
The Franciscan Missionaries of Our Lady Health System announced this morning it will mandate COVID-19 vaccinations,
This Company Ships Cannabis Products From Colombia To The US: Meet The Latino Behind It
By Hernán Paness…
J&J in talks with government to finalise Covid-19 vaccine plan
India Business News: US major Johnson & Johnson reiterated on Monday that it remains committed to bringing its single-dose Covid-19 vaccine to the country, and is stil
Global Orthopedic Veterinary Implants Market to Reach $159.9 Million by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Who Can Mandate Covid-19 Vaccination?
As the Delta variant complicates return to “normal,” universities, employers and municipal governments take the “soft mandate” route—get vaccinated or face the consequences.
Covid-19-Erkrankung trotz Impfung: Wie gefährlich sind Impfdurchbrüche?
Die Impfstoffe sind hochwirksam gegen Corona. Trotzdem gibt es tausende Menschen, die vollständig geimpft werden und trotzdem erkranken.
Global $12.87 Bn Knee Replacement Market to 2027
/PRNewswire/ — The “Knee Replacement Market Global Forecast Industry Trends, Growth, Opportunity By Products, Regions, Company Analysis” report has been added…
Tougher terms: why the EU is paying more for new COVID shots
BRUSSELS — The European Union has agreed to pay a premium on new orders of COVID-19 vaccines because it is requiring tougher terms to be met, European…
Duterte says geopolitics, vaccine supply prompted him to retain US military pact
President Duterte on Monday said the country would keep its close ties with the US despite recent calls of some American lawmakers for a probe into the government’s war against illegal drugs. During his latest public address, Duterte disclosed that the country maintains close affinity with the US government due…
3 Reasons Why Pfizer's and Moderna's Vaccine Revenue Growth Is Just Getting Started
These elements may represent billions of dollars in the months and years to come.
Why Data Management Is Critical For Faster Drug Development
Data management is the next-generation toolkit for pharmaceutical companies and their researchers.
Mestag extends seed financing to $45m with new backers
Mestag Therapeutics in Cambridge, a breakthrough inflammatory disease and immuno-oncology company, has closed an oversubscribed seed round extension to take the total to $45 million. The extension of $34m was led by Amsterdam-based investment firm Forbion together with global healthcare investors GV (formerly Google Ventures) and Northpond Ventures and supported by founding
Assembly Bio Announces Key Promotions To Leadership Team
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing
Sanofi bets on mRNA vaccines beyond COVID in $3.2 bln Translate Bio deal
PARIS — Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA vaccine technology beyond the…
Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE…
How the Delta Variant Could Change the World of Coronavirus Vaccine Stocks
It'll push the winners further ahead of the laggards.
What to know: Delta variant and Covid shots
“Authorised vaccines effectively prevent serious illness and hospitalization, research shows,” writes The Wall Street Journal.
Demystifying the Delta variant
The delta variant mutations which alone don’t present particularly significant conclusions, appear to be more formidable as a team.
Sanofi bets on mRNA vaccines beyond COVID in $3.2 bn Translate Bio deal
Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion.
Covid returns to China's Wuhan as global Delta variant woes mount
Covid returns to China's Wuhan as global Delta variant woes mount
COVID-19 vaccine tracker: Over 61 lakh doses administered in India on August 2
On the 199th day of the vaccination drive on August 2, 61,09,587 new vaccination doses were given, taking the total coverage to over 47.85 crore.
Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 billion deal
Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters… | August 3, 2021
Analysis: Tougher terms: why the EU is paying more for new COVID shots By Reuters
Analysis: Tougher terms: why the EU is paying more for new COVID shots